Medicine and Dentistry
Venous Thromboembolism
86%
Heparin
56%
Thrombosis
49%
Phlebothrombosis
42%
Pulmonary Embolism
38%
Deep Vein Thrombosis
34%
Antithrombotic
33%
Apixaban
33%
Bleeding
27%
Warfarin
25%
Low Molecular Weight Heparin
22%
Thromboprophylaxis
21%
Thromboembolism
18%
Anticoagulant Therapy
18%
Global Disease Burden
18%
Fibrinogen
18%
Diseases
17%
Hip Replacement
15%
Major Bleeding
13%
Apoplexy
12%
Brain Ischemia
11%
Plasminogen Activator
11%
Malignant Neoplasm
10%
Fibrinolytic Therapy
10%
Recurrent Disease
10%
Blood Clotting
9%
Platelet
9%
Dextran
9%
Thrombus
9%
Iodine 125
9%
Thrombolytic Drug
9%
Clinical Trial
8%
Leg Thrombosis
8%
Low Drug Dose
8%
Knee Replacement
8%
Myocardial Infarction
8%
Acetylsalicylic Acid
7%
Streptokinase
7%
Heart Valve Prosthesis
7%
Ischemic Heart Disease
6%
Venography
6%
Blood Stasis
6%
Disease
6%
Anticoagulant
6%
Systematic Review
6%
Anticoagulation
6%
Urokinase
6%
Orthopedic Surgery
5%
Disability Adjusted Life Years
5%
Subcutaneous Injection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
100%
Heparin
61%
Warfarin
53%
Bleeding
43%
Anticoagulant Agent
41%
Thrombosis
38%
Apixaban
29%
Vein Thrombosis
29%
Deep Vein Thrombosis
28%
Lung Embolism
26%
Enoxaparin
20%
Low Molecular Weight Heparin
17%
Recurrent Disease
16%
Diseases
16%
Fibrinogen
15%
Rivaroxaban
14%
Global Disease Burden
14%
Fondaparinux
13%
Acetylsalicylic Acid
11%
Placebo
11%
Idraparinux
11%
Cerebrovascular Accident
10%
Brain Ischemia
10%
Subcutaneous Injection
10%
Thromboembolism
9%
Sulfinpyrazone
9%
Clinical Trial
9%
Prospective Study
8%
Malignant Neoplasm
8%
Fibrinolytic Agent
7%
Heart Infarction
7%
Maintenance Dose
7%
Danaparoid
7%
Blood Stasis
7%
Antithrombin
7%
Antiplatelet
7%
Iodine-125
6%
Thromboplastin
6%
Antivitamin K
6%
Thrombocytopenia
5%
Streptokinase
5%
Dextran
5%
Ischemic Heart Disease
5%
Prothrombin
5%
Prothrombin Complex
5%
Fresh Frozen Plasma
5%
Antithrombocytic Agent
5%
Nursing and Health Professions
Heparin
38%
Vein Thrombosis
22%
Venous Thromboembolism
21%
Deep Vein Thrombosis
14%
Low Molecular Weight Heparin
13%
Lung Embolism
10%
Warfarin
9%
Heparin Induced Thrombocytopenia
7%
Bleeding
6%
Activated Partial Thromboplastin Time
5%
Thrombosis
5%
Outpatient
5%
Practice Guideline
5%
Subcutaneous Injection
5%
Thrombocytopenia
5%
Anticoagulant Agent
5%
Recurrent Disease
5%